Advertisement

The underrecognized role of primary care physicians in the prevention and management of chronic kidney disease

  • Alice Pik-Shan Kong
    Correspondence
    Corresponding author at: Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
    Affiliations
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

    Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

    Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
    Search for articles by this author
  • Philip Kam-Tao Li
    Affiliations
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
    Search for articles by this author
Published:January 17, 2023DOI:https://doi.org/10.1016/j.pcd.2023.01.006
      The prevalence of end-stage renal disease is rising across the globe, with diabetes as the leading cause in half of those affected [
      • Burrows N.R.
      • Koyama A.
      • Pavkov M.E.
      Reported Cases of End-Stage Kidney Disease - United States, 2000-2019.
      ]. As a result of global industrialization with the popularity of unhealthy diets and physical inactivity, obesity and diabetes are epidemics affecting many individuals worldwide including the youth populations. The decline in the age of onset of diabetes and the increased risk of cardio-renal complications in young-onset diabetes are especially worrisome [
      • Luk A.O.
      • Lau E.S.
      • So W.Y.
      • Ma R.C.
      • Kong A.P.
      • Ozaki R.
      • Chow F.C.
      • Chan J.C.
      Prospective study on the incidences of cardiovascular-renal complications in chinese patients with young-onset type 1 and type 2 diabetes.
      ]. Furthermore, the impact of the recent coronavirus disease 2019 (COVID-19) pandemic and its related influence on the change of lifestyle habits and the consequences on physical and mental health remain to be seen in the long run [
      • Lim S.
      • Kong A.P.
      • Tuomilehto J.
      Influence of COVID-19 pandemic and related quarantine procedures on metabolic risk. Prim Care.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Burrows N.R.
        • Koyama A.
        • Pavkov M.E.
        Reported Cases of End-Stage Kidney Disease - United States, 2000-2019.
        MMWR Morb. Mortal. Wkly Rep. 2022; 71: 412-415https://doi.org/10.15585/mmwr.mm7111a3
        • Luk A.O.
        • Lau E.S.
        • So W.Y.
        • Ma R.C.
        • Kong A.P.
        • Ozaki R.
        • Chow F.C.
        • Chan J.C.
        Prospective study on the incidences of cardiovascular-renal complications in chinese patients with young-onset type 1 and type 2 diabetes.
        Diabetes Care. 2014; 37: 149-157
        • Lim S.
        • Kong A.P.
        • Tuomilehto J.
        Influence of COVID-19 pandemic and related quarantine procedures on metabolic risk. Prim Care.
        Diabetes. 2021; 15: 745-750https://doi.org/10.1016/j.pcd.2021.07.008
        • Li P.K.T.
        • Garcia-Garcia G.
        • Lui S.F.
        • Andreoli S.
        • Fung W.W.S.
        • Hradsky A.
        • Kumaraswami L.
        • Liakopoulos V.
        • Rakhimova Z.
        • Saadi G.
        • Strani L.
        • Ulasi I.
        • Kalantar-Zadeh K.
        • for World Kidney Day Steering Committee
        Kidney health for everyone everywhere - from prevention to detection and equitable access to care.
        Kidney Int. 2020; 97: 226-232
        • American Diabetes Association Professional Practice Committee
        Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes 2022.
        Diabetes Care. 2022; 45: S125-S143https://doi.org/10.2337/dc22-S009
        • Rossing P.
        • Caramori M.L.
        • Chan J.C.N.
        • Heerspink H.J.L.
        • Hurst C.
        • Khunti K.
        • Liew A.
        • Michos E.D.
        • Navaneethan S.D.
        • Olowu W.A.
        • Sadusky T.
        • Tandon N.
        • Tuttle K.R.
        • Wanner C.
        • Wilkens K.G.
        • Zoungas S.
        • Craig J.C.
        • Tunnicliffe D.J.
        • Tonelli M.A.
        • Cheung M.
        • Earley A.
        • de Boer I.H.
        Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence.
        Kidney Int. 2022; 102: 990-999https://doi.org/10.1016/j.kint.2022.06.013
        • Flory J.H.
        • Guelce D.
        • Goytia C.
        • Li J.
        • Min J.Y.
        • Mushlin A.
        • Orloff J.
        • Mayer V.
        Prescriber uncertainty as opportunity to improve care of type 2 diabetes with chronic kidney disease: mixed methods study.
        J. Gen. Intern Med. 2022; https://doi.org/10.1007/s11606-022-07838-1
        • Seidu S.
        • Cos Xavier
        • Topsever P.
        Self-rated knowledge and competence regarding the management of chronic kidney disease in primary care: a cross-sectional European survey of primary care professionals.
        Prim. Care Diabetes. 2023;